Complete Up To Date Information about Optimmune .
NADA Number: 141-052 | |
| Proprietary Name |
Optimmune® |
|---|---|
| Sponsor |
Schering-Plough Animal Health Corp. |
| Sponsor Address |
P.O. Box 21 Sandown Village, NJ 3171 VIC Australia |
| Ingredients |
Cyclosporine |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Opthalmological |
| Dose Form |
Ointment |
| Drug Form |
Ointment |
| Dispensing Status |
RX |
| Patent Number |
4649047 4839342 5411952 |
| Exclusivity |
No active ingredient of the drug has been previously approved. Granted for the management of chronic superficial keratitis in dogs. |
|
Dosage Amount, Indications & Limitations |
524.575 Cyclosporine ophthalmic ointment. Specifications: Each gram of ointment contains 2 milligrams of cyclosporine. Conditions of use: Dogs Amount: Apply a 1/4 inch strip of ointment to the affected eye(s) every 12 hours. Indications: For treatment of chronic keratoconjunctivitis sicca in dogs. Limitations: Place ointment directly on cornea or into the conjunctival sac. Safety of use in puppies, pregnant or breeding animals has not been determined. |